About
Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com
Technologies
Gmail
Google Apps
Google Cloud Hosting
Varnish
Mobile Friendly
Wix
Node.js
Android
Circle
Remote
Render
AI
IoT
Keywords
medical device
pediatrics
neonatology
neonatal intensive care
therapy
apnea of prematurity
neonatal abstinence syndrome
intermittenty hypoxemia
hypoxia
neonatal incubators
infant sleep
respiratory synctial virus
medical equipment manufacturing
neonatal health improvement
apnea reduction device
fda-authorized medical device
neonatal apnea treatment
medical equipment and supplies manufacturing
non-pharmacological therapy
medical device grants
stochastic resonance
infant sleep cycle support
neonatal care
fda breakthrough device
neonatal health research
neonatal therapy device
neonatal treatment technology
stochastic vibrotactile stimulation
infant care equipment
neonatal treatment device
Company Information
-
Employees 3
-
Founded 2017
-
Total Funding $3700000
Location
2 Monument Sq, Portland, Maine, United States, 04101-4032
